No Picture
News

Selections from DISORDER: The Rare Disease Film Festival to show during Biotech Week Boston this September

CARLSBAD, Calif. and BOSTON, Aug. 8, 2019 /PRNewswire/ — The second annual Selections from DISORDER: The Rare Disease Film Festival at Biotech Week Boston will be held at the Takeda Auditorium in Cambridge, MA, on September 12 from… […]

No Picture
News

Halozyme Reports Second Quarter 2019 Results

– Total Revenues Increase 11% to $39.1 Million Compared to $35.2 Million in Prior-year Period — ENHANZE® Partner Janssen Submits Regulatory Applications for Subcutaneous Formulation of DARZALEX® in the U.S. and EU — Pivotal Phase 3 Trial Results from… […]

No Picture
News

Evofem Biosciences Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Amphora NDA Resubmission Remains on Track for Q4 2019Management to Host Conference Call Tuesday August 6, 2019 at 11:00 a.m. EDT

SAN DIEGO, Aug. 5, 2019 /PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ: EVFM) (“Evofem” or the “Company”), a clinical … […]

No Picture
News

Evofem Biosciences Reports Additional Data from Phase 3 ‘AMPOWER’ Study of Amphora® for Hormone-Free Birth Control

SAN DIEGO, Aug. 5, 2019 /PRNewswire/ — Evofem Biosciences, Inc. (NASDAQ: EVFM) (Evofem), a clinical-stage biopharmaceutical company, today reported additional data from its Phase 3 ‘AMPOWER’ clinical trial of Amphora® for the prevention of pregnanc… […]

No Picture
News

Roche to showcase how health networks are driving change through innovation in the lab and beyond at AACC 2019 Clinical Lab Expo

– Featured health networks improve patient care through innovative technologies and optimizing operations- Digital tools harness rich data streams to provide clinical decision support, patient insights and improved operational effectiveness

INDIANAPO… […]

No Picture
News

Tocagen to Report Second Quarter 2019 Financial Results and Business Updates on Thursday, August 8

SAN DIEGO, Aug. 1, 2019 /PRNewswire/ — Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced it will report its second quarter 2019 financial results and business progress on Thursday, August 8, 2019,… […]

No Picture
News

Viking Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Conference call scheduled for 4:30 p.m. ET today- Preparation for Phase 2b Study of VK2809 in Biopsy-Confirmed NASH Underway; Expect to Commence Enrollment in 2H19- Continued Progress with VK0214 for X-ALD; Expect to Commence Phase 1 Clinical Study in … […]